Genetic Basis of Congenital and Infantile Nephrotic Syndromes
To the Editor:
We conducted a nationwide multicenter study to analyze phenotype and genotype of 30 unrelated Korean children with nephrotic syndrome in the first year of life, including 15 patients with congenital and 15 with infantile nephrotic syndrome. 1 Mutations were detected in 17 individuals (56.7% overall; 93.3% and 20.0% of patients with congenital and infantile nephrotic syndrome, respectively), in the WT1 (n ϭ 8), NPHS1 (n ϭ 6), LAMB2 (n ϭ 2), and NPHS2 (n ϭ 1) genes; no polymorphisms were detected in the PLCE1 gene [2] [3] [4] [5] (Table 1) . The frequency of mutations in patients with congenital nephrotic syndrome was similar to those of 2 large studies of European 7 (84.8%) and multiethnic 8 (81.3%) cohorts. However, in our study, mutations in NPHS2 had the lowest frequency and WT1 mutations were most frequent. Although NPHS1 mutations were detected in only patients with congenital nephrotic syndrome, WT1 mutations were detected in patients from both groups of nephrotic syndrome. WT1 mutations frequently were accompanied by diffuse mesangial sclerosis, genitalia anomalies, or diaphragmatic defects. Of 17 patients with mutations, 11 developed an estimated glomerular filtration rate Ͻ60 mL/min/1.73 m 2 or end-stage renal disease, 3 died, and 3 had persistent active nephrotic syndrome. Immunosuppressive drugs were administered to 8 patients with infantile ne- Inulin clearance (Cin) has been considered the reference standard for measuring glomerular filtration rate (GFR). Because of the inconvenience of Cin in clinical practice, in some countries, technetium-99m diethylenetriaminepentaacetic acid 
